JPS62207236A - Phenoxyalkanoic acid derivative - Google Patents
Phenoxyalkanoic acid derivativeInfo
- Publication number
- JPS62207236A JPS62207236A JP61050015A JP5001586A JPS62207236A JP S62207236 A JPS62207236 A JP S62207236A JP 61050015 A JP61050015 A JP 61050015A JP 5001586 A JP5001586 A JP 5001586A JP S62207236 A JPS62207236 A JP S62207236A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- reaction
- lower alkyl
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002253 acid Substances 0.000 title claims abstract description 17
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 27
- 125000002252 acyl group Chemical group 0.000 claims abstract description 23
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 14
- 125000006239 protecting group Chemical group 0.000 claims abstract description 10
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims 1
- -1 halide compound Chemical class 0.000 abstract description 51
- 238000006243 chemical reaction Methods 0.000 abstract description 39
- 150000001875 compounds Chemical class 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 150000002148 esters Chemical class 0.000 abstract description 3
- 230000037356 lipid metabolism Effects 0.000 abstract description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 abstract description 2
- 229940031016 ethyl linoleate Drugs 0.000 abstract description 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 abstract description 2
- OVBFMEVBMNZIBR-UHFFFAOYSA-N -2-Methylpentanoic acid Natural products CCCC(C)C(O)=O OVBFMEVBMNZIBR-UHFFFAOYSA-N 0.000 abstract 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 36
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 26
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 13
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 150000002170 ethers Chemical class 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 4
- 239000012442 inert solvent Substances 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 3
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 3
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000004292 cyclic ethers Chemical group 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 125000004665 trialkylsilyl group Chemical group 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- JQCSUVJDBHJKNG-UHFFFAOYSA-N 1-methoxy-ethyl Chemical group C[CH]OC JQCSUVJDBHJKNG-UHFFFAOYSA-N 0.000 description 1
- 125000001088 1-naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- XRUGBBIQLIVCSI-UHFFFAOYSA-N 2,3,4-trimethylphenol Chemical compound CC1=CC=C(O)C(C)=C1C XRUGBBIQLIVCSI-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical group CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- QAWBXZYPFCFQLA-UHFFFAOYSA-N butanoyl bromide Chemical compound CCCC(Br)=O QAWBXZYPFCFQLA-UHFFFAOYSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- MXOSTENCGSDMRE-UHFFFAOYSA-N butyl-chloro-dimethylsilane Chemical compound CCCC[Si](C)(C)Cl MXOSTENCGSDMRE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- NKLCHDQGUHMCGL-UHFFFAOYSA-N cyclohexylidenemethanone Chemical group O=C=C1CCCCC1 NKLCHDQGUHMCGL-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- CEALXSHFPPCRNM-UHFFFAOYSA-L disodium;carboxylato carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OC([O-])=O CEALXSHFPPCRNM-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000000687 hydroquinonyl group Chemical class C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002900 organolithium compounds Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 125000003808 silyl group Chemical class [H][Si]([H])([H])[*] 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
【発明の詳細な説明】
発明の目的
近年、生体内過酸化脂質が循環器系障害の一要因と考え
られているが、本発明者らは、か\る観点より脂質代謝
改善薬の開発を目的として立体R’dFフェノール系化
合物について鋭意研究を行ない、後記一般式il+を有
するフェノキシアルカ/酸誘導体が血中脂質代謝改善作
用を有することを見出して本発明を完成するに至った。[Detailed Description of the Invention] Purpose of the Invention In recent years, lipid peroxide in the body has been considered to be a cause of circulatory system disorders. For this purpose, we conducted extensive research on steric R'dF phenolic compounds, and found that a phenoxyalka/acid derivative having the general formula il+ described below has an effect on improving blood lipid metabolism, leading to the completion of the present invention.
発明の構成
本発明の新規なフェノキシアルカ/酸誘導体は、一般式
で表わされる化合物およびその薬理上許容される塩であ
る。Structure of the Invention The novel phenoxyalka/acid derivatives of the present invention are compounds represented by the general formula and pharmacologically acceptable salts thereof.
上記式中、RおよびRは同一または異なって低級アルキ
ル基を示し、Rは水素原子または低級アルキル基を示し
、Rは水素原子または水酸基の保穫基を示し、Rは水素
原子、アルキル基または低級アルコキシ基を示し、Rは
水素原子、低級アルキル基または低級アルコキシ基を示
し、2は式−COOR基(式中、Rは水素原子または低
級アルキル基を示す。)または式−CH20R基(式中
、Rは水素原子またはアシル基を示す。)を示し、nは
1乃至10の整数を示す。In the above formula, R and R are the same or different and represent a lower alkyl group, R represents a hydrogen atom or a lower alkyl group, R represents a hydrogen atom or a hydroxyl group, R represents a hydrogen atom, an alkyl group, or represents a lower alkoxy group, R represents a hydrogen atom, a lower alkyl group, or a lower alkoxy group; 2 represents a -COOR group (wherein R represents a hydrogen atom or a lower alkyl group) or a -CH20R group (the formula (wherein, R represents a hydrogen atom or an acyl group), and n represents an integer of 1 to 10.
前記一般式(1)において、RおよびRは同一または異
なって直鎖状若しくは分枝鎖状の炭素数1乃至5のアル
キル基を示し、Rは水素原子または直鎖状若しくは分枝
鎖状の炭素数1乃至5のアルキル基を示し、Rは水素原
子または水酸基の保護基として炭Xa2乃至6の脂肪族
アシル基、芳香族アシル基、芳香脂肪族アシル基、脂環
式アシル基若しくは複素環アシル基などのアシル基を示
し、Rは水素原子、直鎖状若しくは分枝鎖状の炭素数1
乃至10のアルキル基または直鎖状若しくは分枝鎖状の
炭素数1乃至5のアルコキシ基、Rは水素原子、直鎖状
若しくは分枝鎖状の炭素数1乃至5のアルキル基または
直鎖状若しくは分校鎖状の炭素数1乃至5のアルコキシ
基を示し、2は式−COOR基(式中、Rは水素原子ま
たは直鎖状若しくは分枝鎖状の炭素数1乃至5のアルキ
ル基を示す。)または式−CH20R基(式中、Rは水
素原子または炭素数2乃至6の脂肪族アシル基、芳香族
アシル基、芳香脂肪族アシル基、脂環式アシル基若しく
は複素環アシル基などのアシル基を示す。)を示し、n
は1乃至10の整数を示す。In the general formula (1), R and R are the same or different and represent a linear or branched alkyl group having 1 to 5 carbon atoms, and R is a hydrogen atom or a linear or branched alkyl group. R represents an alkyl group having 1 to 5 carbon atoms, and R is a hydrogen atom or a protecting group for a hydroxyl group, such as an aliphatic acyl group, an aromatic acyl group, an araliphatic acyl group, an alicyclic acyl group, or a heterocycle having carbons Xa 2 to 6. Indicates an acyl group such as an acyl group, R is a hydrogen atom, a linear or branched chain with 1 carbon number
1 to 10 alkyl groups or linear or branched alkoxy groups having 1 to 5 carbon atoms, R is a hydrogen atom, linear or branched alkyl groups having 1 to 5 carbon atoms, or linear or a branched chain alkoxy group having 1 to 5 carbon atoms; 2 is a group of the formula -COOR (wherein R represents a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms; ) or a -CH20R group (wherein R is a hydrogen atom or a C2-C6 aliphatic acyl group, aromatic acyl group, aromatic aliphatic acyl group, alicyclic acyl group, heterocyclic acyl group, etc.) ) represents an acyl group, and n
represents an integer from 1 to 10.
前記一般式(!りにおいて、
RjR,R,RおよびRがアルキル基を示す場合、R,
R,R,RおよびRとして同一または異なってメチル、
エチル、プロピル、イソプロピル、ブチル、イソブチル
、ペンチル、インペンチル、2−メチルブチルまたは1
−エチルプロピルのような炭素数1乃至5のものがあげ
られ、
R5がアルキル基を示す場合、Rとしてメチル、エチル
、プロピル、イソプロピル、ブチル、イソブチル、te
rt−ブチル、ペンチル、インペンチル、ネオペンチル
、 tart−ペンチル、へ中シル、1,1−ジメチル
ブチル、1.3−ジメチルブチル、ヘプチル、オクチル
、1−メチルヘプチル、2−エチルへ中シル、1.1.
3.3−テトラメチルブチル、ノニル、デシルまたはλ
T−ジメチルオクチルのような炭素数1乃至10のもの
があげられ、
R5およびRがアルコキシ基を示す場合、RおよびRと
して同一または異なってメトキシ、エトキシ、プロポキ
シ、インプロポキシ、ブトキシ、インブトキシ、ぺ/チ
ルオキシのような炭素数1乃至5のものがあげられ、
R4およびRがアシル基を示す場合、RおよびR8とし
て同一または異なってアセチル、プロピオニル、ブチリ
ル、インブチリル、ピバロイル、ヘキサメイル、アクリ
ロイル、メタクリロイルまたはクロトノイルのような不
飽和結合を有していてもよい炭素数2乃至6の脂肪族ア
シル基:ペンゾイル、p−)ルオイル、0−7ニソイル
、4−ニトロベンゾイル、3−フルオロペンソイル、2
−クロロベンゾイル、4−7ミノペンゾ、イル、3−ジ
メチルアミノベンゾイル、3.4−ジクロロベンゾイル
、1−ナフトイルのような芳香族アシル基;フェニルア
セチル、4−クロロフェニルアセチル、3−フェニルプ
ロピオニルまたはシンナモイルのような不飽和結合を有
していてもよい芳香脂肪族アシル基ニジクロペンタンカ
ルボニル、シクロヘキサンカルボニル、シクロヘプタン
カルボニルのような脂環式アシル基:または2−フロイ
ル、3−テノイル、3−ピリジンカルボニル、4−ピリ
ジンカルボニルのような複素環アシル基があげられる。In the general formula (!), when RjR, R, R and R represent an alkyl group, R,
R, R, R and R are the same or different, methyl,
Ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, impentyl, 2-methylbutyl or 1
- C1 to C5 such as ethylpropyl, and when R5 represents an alkyl group, R is methyl, ethyl, propyl, isopropyl, butyl, isobutyl, te
rt-butyl, pentyl, impentyl, neopentyl, tart-pentyl, hechusyl, 1,1-dimethylbutyl, 1,3-dimethylbutyl, heptyl, octyl, 1-methylheptyl, 2-ethyl hechusyl, 1 .1.
3.3-Tetramethylbutyl, nonyl, decyl or λ
Examples include those having 1 to 10 carbon atoms such as T-dimethyloctyl, and when R5 and R represent an alkoxy group, R and R may be the same or different and include methoxy, ethoxy, propoxy, impropoxy, butoxy, imbutoxy, When R4 and R represent an acyl group, R and R8 may be the same or different and include acetyl, propionyl, butyryl, imbutyryl, pivaloyl, hexamethyl, acryloyl, methacryloyl. or an aliphatic acyl group having 2 to 6 carbon atoms which may have an unsaturated bond such as crotonoyl: penzoyl, p-)luoyl, 0-7 disoyl, 4-nitrobenzoyl, 3-fluoropenzoyl, 2
- aromatic acyl groups such as chlorobenzoyl, 4-7 minopenzoyl, 3-dimethylaminobenzoyl, 3,4-dichlorobenzoyl, 1-naphthoyl; phenylacetyl, 4-chlorophenylacetyl, 3-phenylpropionyl or cinnamoyl; An aromatic aliphatic acyl group which may have an unsaturated bond such as a cycloaliphatic acyl group such as dichlorpentanecarbonyl, cyclohexanecarbonyl, cycloheptanecarbonyl: or 2-furoyl, 3-thenoyl, 3-pyridinecarbonyl , 4-pyridinecarbonyl and other heterocyclic acyl groups.
本発明の前記一般式+11で表わされる目的化合物が酸
性の基を有するときには、常法に従?て薬理上許容し得
る無毒性塩とすることができるが、そのような塩として
例えばナトリウム、カリウムのようなアルカリ金属の塩
あるいはカルシウムのようなアルカリ土類金属の塩など
をあげることかできる。When the target compound of the present invention represented by the general formula +11 has an acidic group, the conventional method may be used. Examples of such salts include salts of alkali metals such as sodium and potassium, and salts of alkaline earth metals such as calcium.
さらに、本発明の化合物(11において、好適な化合物
としては、RおよびRが直鎖状若しくは分枝鎖状の炭素
数1乃至3のアルキル基、特にメチル基であり 、R、
RおよびRが水素原子または直鎖状若しくは分校鎖状の
炭素数1乃至3のアルキル基、特に水素原子またはメチ
ル基であり:R4中櫨啼袖奔が水素原子、アセチル基ま
たはベンゾイル基、特に水素原子であり:R5が直鎮状
若しくは分枝鎖状の炭素数1乃至8のアルキル基、特に
メチル、 tart−ブチルまたは1,1.λ3−テト
ラメチルブチル基であり;nが2乃至8の整数、特に3
乃至Tの整数であり二2が式−cH20R基(Rは水素
原子、アセチル基またはベンゾイル基を示す。)、特に
式−cm2on基である化合物をあげることができる。Furthermore, suitable compounds for the compound of the present invention (11) include R and R being a linear or branched alkyl group having 1 to 3 carbon atoms, particularly a methyl group;
R and R are a hydrogen atom or a linear or branched chain alkyl group having 1 to 3 carbon atoms, especially a hydrogen atom or a methyl group; is a hydrogen atom; R5 is a straight or branched alkyl group having 1 to 8 carbon atoms, particularly methyl, tart-butyl or 1,1. λ3-tetramethylbutyl group; n is an integer of 2 to 8, especially 3
Mention may be made of compounds in which 22 is an integer of the formula -cH20R (R represents a hydrogen atom, an acetyl group or a benzoyl group), in particular a -cm2on group.
本発明のフェノキシアルカン酸誘導体の具体例としては
例えば以下に示すような構造式を有する化合物(第−表
および第二衣)があげられる。Specific examples of the phenoxyalkanoic acid derivatives of the present invention include compounds having the structural formulas shown below (Table 1 and Table 2).
なお、以下の表において、TMBは1.1.3.3−テ
トラメチルブチル基を示す。In addition, in the table below, TMB represents a 1.1.3.3-tetramethylbutyl group.
第 二 表
本発明のフェノキ、シアルカン酸誘導体11)は、例え
ば以下に示す方法によって製造することができる。Table 2 The phenyl sialkanoic acid derivative 11) of the present invention can be produced, for example, by the method shown below.
121 ’ (1a)上記
式中、RjR,R,R,、Rおよびnは前述したものと
同意義を示し、Raは水素原子を示し、Bは例えばメト
キシエチル、1−メトキシエチルのような1−低級アル
コギシアルキル基、テトラヒドロピラニルのような環状
エーテル基、トリメチルシリル、ジメチル−1−ブチル
シリルのようなトリアルキルシリル基またはベンジル、
p−メトキシベンジル、p−ブロムベンジルのようなア
ラルキル基などの水酸基の保護基を示し、Xは塩素、臭
素、沃素のようなハロゲン原子を示し、Yはナトリウム
、カリウムのようなアルカリ金属原子を示す。121' (1a) In the above formula, RjR, R, R,, R and n have the same meanings as defined above, Ra represents a hydrogen atom, and B represents 1 such as methoxyethyl or 1-methoxyethyl. - lower alkoxyalkyl groups, cyclic ether groups such as tetrahydropyranyl, trialkylsilyl groups such as trimethylsilyl, dimethyl-1-butylsilyl, or benzyl;
It represents a hydroxyl protecting group such as an aralkyl group such as p-methoxybenzyl or p-bromobenzyl, X represents a halogen atom such as chlorine, bromine, or iodine, and Y represents an alkali metal atom such as sodium or potassium. show.
第1工程は、ハライド化合物(2)にカルバニオン(3
)全反応させ、ついで得られた反応生成物より水酸基の
保詮基を除去して、本発明の目的化合物(1a)を得る
工程である。In the first step, the carbanion (3) is added to the halide compound (2).
) This is a step in which the target compound (1a) of the present invention is obtained by carrying out a complete reaction and then removing the hydroxyl group-protecting group from the obtained reaction product.
はじめのハライド(2)とカルバニオン(3)との反応
は、Qra 、Syn、 50巻、58頁記載の方法に
準じて実施することができる。The reaction between the initial halide (2) and carbanion (3) can be carried out according to the method described in Qra, Syn, Vol. 50, p. 58.
すなわち、
(式中、RおよびRは前述したものと同意義を示す。)
を有するカルボン酸を不活性溶剤中で塩基で処(2)と
反応させることによって達成される。使用される塩基と
しては、例えば水素化リチウム、水素化ナトリウム、水
素化カリウムのようなアルカリ金属水素化物、メチルリ
チウム、ブチルリチウム、tart−ブチルリチウム、
フェニルリチウムのような有機リチウム化合物またはリ
チウム ジイソプロピルアミド、リチウム ジシクロへ
キシルアミドのようなリチウム ジアルキルアミド類が
あげられる。使用される不活性溶剤としては反応に関与
しなければ特に限定されないが、例えばエーテル、テト
ラヒドロフラン、ジオキサンのようなエーテル類、また
はジメチルホルムアミド、ジメチルアセトアミドのよう
なアミド類をあげることができる。反応己屓は0℃乃至
80℃であり、反応に要する時間は1時間乃至24時間
である。That is, it is achieved by reacting a carboxylic acid having the formula (wherein R and R have the same meanings as defined above) with (2) in an inert solvent with a base. Bases used include, for example, alkali metal hydrides such as lithium hydride, sodium hydride, potassium hydride, methyllithium, butyllithium, tart-butyllithium,
Examples include organolithium compounds such as phenyllithium or lithium dialkylamides such as lithium diisopropylamide and lithium dicyclohexylamide. The inert solvent to be used is not particularly limited as long as it does not participate in the reaction, but examples thereof include ether, ethers such as tetrahydrofuran and dioxane, and amides such as dimethylformamide and dimethylacetamide. The temperature of the reaction is 0°C to 80°C, and the time required for the reaction is 1 to 24 hours.
本反応で製造された、フェノール性水酸基の保護された
カルボン欧誘導体
(式中、R,R,R,R,R,Bおよびnは前述したも
のと同意義を示す。)は単離してもよいが、通常は単離
することなく、次の脱保護反応を行なうことができる。The carbon derivative with a protected phenolic hydroxyl group (in the formula, R, R, R, R, R, B and n have the same meanings as described above) produced by this reaction can be isolated. However, the next deprotection reaction can usually be carried out without isolation.
脱保紐反応は保護基のdi類に従って、通常の方法で実
施することができるが、例えば水酸基の保護基がトリア
ルキル置換シリル基の場合は水ちるいは暇を含有する水
と接触させることにより容易に達成される。その場合の
含有される酸としては例えばギ酸、醪酸、シュウ酸のよ
うな刊概販、塩酸、拠化水索戚、硫酸のような鉱酸など
の酸が特に限定なく使用される。反応は溶剤として水を
使用すれば他の溶剤は特に必要ではない。他の溶剤を使
用する場合は、例えばテトラヒドロフラン、ジオキサン
のようなエーテル類、メタノール、エタノールのような
アルコール類などの有機溶剤と水との混合溶剤が使用さ
れる。反応温度には特に限定はないが、通常は室温付近
で好適に行なわれる。反応に要する時間は30分間乃至
5時間である。また、テトラヒドロフラン、ジオギサン
のようなエーテル類または酢龜のような脂肪酸中でフッ
化テトラブチルアンモニウムで処理することによっても
達成される。The unbinding reaction can be carried out in a conventional manner according to the di class of the protecting group, but for example, when the protecting group for a hydroxyl group is a trialkyl-substituted silyl group, it may be carried out by contacting it with water or water containing water. easily achieved by The acids to be contained in this case include, without particular limitation, acids such as formic acid, ceric acid, and oxalic acid, and mineral acids such as hydrochloric acid, hydrochloric acid, and sulfuric acid. In the reaction, if water is used as a solvent, no other solvent is particularly required. When using other solvents, for example, a mixed solvent of water and an organic solvent such as ethers such as tetrahydrofuran and dioxane, and alcohols such as methanol and ethanol is used. The reaction temperature is not particularly limited, but it is usually suitably carried out around room temperature. The time required for the reaction is 30 minutes to 5 hours. It is also achieved by treatment with tetrabutylammonium fluoride in ethers such as tetrahydrofuran, dioxane, or fatty acids such as vinegar.
上記の反応によって製造されたフェノキシアルカン酸紳
導体(1a)は、所望により通常行なわれるエステル化
法、さらに必要に応じてアシル化法に従って、本発明の
目的化合物である対応するエステル
(式中、R,R,R,R,R,Rおよびnは前述したも
のと同意義を示し、Rbは低級アルキル基を示す。)
に変換することができる。The phenoxyalkanoic acid conductor (1a) produced by the above reaction is subjected to a conventional esterification method and, if necessary, an acylation method, to obtain the corresponding ester, which is the target compound of the present invention (in the formula: R, R, R, R, R, R and n have the same meanings as described above, and Rb represents a lower alkyl group.
第2工程は、フェノキシアルカン酸誘導体(1a)また
は(1c)を還元して、本発明の目的化合物である対応
するアルコール類(1b)を得る工程である。The second step is a step of reducing the phenoxyalkanoic acid derivative (1a) or (1c) to obtain the corresponding alcohol (1b), which is the target compound of the present invention.
本還元工程は、カルボン酸類をアルコール類に変換する
通常の方法に従って実施することができるが、使用され
る還元剤としては例えばリチウムアルミニウムヒドリド
もしくはビトライド(ソディウム ビス〔2−メトキシ
エトキシ〕アルミナムヒドリド)のような金属ヒドリド
類が好適である。使用される不活性溶剤としては反応に
関与しなければ特に限定はないが、エーテル、テトラヒ
ドロフラン、ジオキサンのようなエーテル類が好適であ
る。反応1度はQC乃至50℃であり、反応に要する時
間は30分間乃至3時間である。This reduction step can be carried out according to a conventional method for converting carboxylic acids into alcohols, and the reducing agent used is, for example, lithium aluminum hydride or bitride (sodium bis[2-methoxyethoxy]aluminum hydride). Metal hydrides such as: The inert solvent used is not particularly limited as long as it does not participate in the reaction, but ethers such as ether, tetrahydrofuran, and dioxane are suitable. The temperature for one reaction is QC to 50°C, and the time required for the reaction is 30 minutes to 3 hours.
本工程の反応によって得られた化合物(1b)は、所望
により通常行なわれるアシル化法に従って、本発明の目
的化合物である対応するアシル化合(式中、R,R、R
、R、Rおよびnは前述したものと同意義を示し、R4
“およびRは同一または異なって前述したアシル基を示
す。)に変換することができる。Compound (1b) obtained by the reaction of this step can be converted to the corresponding acyl compound (in the formula R, R, R
, R, R and n have the same meanings as described above, and R4
"and R are the same or different and represent the above-mentioned acyl group."
以上の反応によって得られたフェノキシアルカン酸誘導
体(1)は、公知の分離、精製手段、例えば濃縮、減圧
濃縮、溶媒抽出、転溶、晶出再結晶、再沈澱、クロマト
グラフィーなどによって単離精製することができる。The phenoxyalkanoic acid derivative (1) obtained by the above reaction is isolated and purified by known separation and purification means such as concentration, vacuum concentration, solvent extraction, dissolution, crystallization recrystallization, reprecipitation, chromatography, etc. can do.
本発明の前記一般式(1)を有する目的化合物を製造す
る際の原料化合物であるハライド化合物(2)は、例え
ば以下に示す方法によって製造することができる。The halide compound (2), which is a raw material compound for producing the target compound having the general formula (1) of the present invention, can be produced, for example, by the method shown below.
上記式中、R,R,R、B、Xおよびnは前述したもの
と同意義を示し、Aはアセチル、プロピオニル、ブチリ
ル、イソブチリル、ピバロイルのような低級脂肪族アシ
ル基を示す。In the above formula, R, R, R, B, X and n have the same meanings as defined above, and A represents a lower aliphatic acyl group such as acetyl, propionyl, butyryl, isobutyryl, and pivaloyl.
A工程は、ハイドロキノン誘導体(4)にカルボン酸の
反応性誘導体を反応させて、化合物(4)の立体障害性
のより小であるフェノール性水酸基をアシル基によって
保護して化合物(5)を製造する工程である。Step A is to react a hydroquinone derivative (4) with a reactive derivative of carboxylic acid to protect the less sterically hindered phenolic hydroxyl group of compound (4) with an acyl group to produce compound (5). This is the process of
使用されるカルボン酸の反応性誘導体としては、例えば
アセチルクロリド、ブチリルプロミド、ピバロイルクロ
リドのような酸ハライドまたは無水酢酸、無水プロピオ
ン酸のような酸無水物があげられるが、好適にはピバロ
イルクロリドのような酸クロリドである。反応に使用さ
れる不活性溶剤としては、反応に関与しないものであれ
ば特に限定はないが、ベンゼン、トルエンのような芳香
族炭化水素類、ジクロロメタン、クロロホルムのような
ハロゲン化炭化水素類、二′−チル、テトラヒドロフラ
ン、ジオキサンのようなエーテル類をあげることができ
る。The reactive derivatives of carboxylic acids used include, for example, acid halides such as acetyl chloride, butyryl bromide, pivaloyl chloride, or acid anhydrides such as acetic anhydride, propionic anhydride, but preferably pivaloyl chloride. It is an acid chloride such as yl chloride. The inert solvent used in the reaction is not particularly limited as long as it does not participate in the reaction, but aromatic hydrocarbons such as benzene and toluene, halogenated hydrocarbons such as dichloromethane and chloroform, dichloromethane, etc. Ethers such as '-thyl, tetrahydrofuran and dioxane can be mentioned.
本アシル化反応は常法に従って脱酸剤の存在下で好適に
行なわれるが、脱酸剤としては例えばトリエチルアミン
、ピリジンのような有機塩基が好ましく、これらを過剰
に使用するときは溶剤を使用しなくてもよい。反応温度
は通常−10℃乃至60℃、好適には室温付近である。This acylation reaction is suitably carried out in the presence of a deoxidizing agent according to a conventional method. As a deoxidizing agent, for example, an organic base such as triethylamine or pyridine is preferable, and if an excessive amount of these is used, a solvent may be used. You don't have to. The reaction temperature is usually -10°C to 60°C, preferably around room temperature.
反応に要する時間は30分間乃至48時間である。The time required for the reaction is 30 minutes to 48 hours.
B工程は、化合物(6)のフェノール性水酸基を保護基
Bによって保護して化合物(6)を製造する工程である
。Step B is a step of protecting the phenolic hydroxyl group of compound (6) with protecting group B to produce compound (6).
本反応は、保護基が1−低級アルコキシアルキル基、ト
リアルキルシリル基またはアラルキル基の場合には、例
えばトリエチルアミン、ピリジン、イミダゾール、水素
化ナトリウムのような塩基の存在下若しくは前処置のの
ち、相当するハライドと反応させることにより達成され
、保護基が1−低級アルコキシアルキル基(炭素数2乃
至4個のもの)tたは環状エーテル基の場合には、例え
ばメタンスルホン醒、p−)ルエンスルホン酸または塩
酸のような酸の存在下、相当するビニルエーテル体(メ
チルビニルエーテル、ジヒドロフラン、ジヒドロピラン
)と反応させることによって達成される。反応に使用さ
れる溶剤としては、反応に関与しなければ特に限足はな
いが、例えばヘキサン、ヘプタンのような脂肪族炭化水
素類、ベンゼン、トルエンのような芳香族炭化水素類、
エーテル、テトラヒドロフラン、ジオキサンのようなエ
ーテル類、ジメチルホルムアミドのようなアミド類、ジ
メチルスルホキシドのようなスルホキシド類があげられ
るが、好適にはジメチルホルムアミドである。反応温度
および反応時間は通常の水酸基を保護する反応と同様で
あるが、好適には室温付近において10乃至24時間か
けて行なわれる。When the protecting group is a 1-lower alkoxyalkyl group, trialkylsilyl group, or aralkyl group, this reaction can be carried out in the presence of a base such as triethylamine, pyridine, imidazole, or sodium hydride, or after a pretreatment. When the protecting group is a 1-lower alkoxyalkyl group (having 2 to 4 carbon atoms) or a cyclic ether group, for example, methanesulfone, p-)luenesulfone, etc. This is achieved by reaction with the corresponding vinyl ether (methyl vinyl ether, dihydrofuran, dihydropyran) in the presence of an acid or an acid such as hydrochloric acid. The solvent used in the reaction is not particularly limited as long as it does not participate in the reaction, but examples include aliphatic hydrocarbons such as hexane and heptane, aromatic hydrocarbons such as benzene and toluene,
Examples include ethers such as ether, tetrahydrofuran, and dioxane, amides such as dimethylformamide, and sulfoxides such as dimethylsulfoxide, and dimethylformamide is preferred. The reaction temperature and reaction time are the same as those for ordinary reactions for protecting hydroxyl groups, but the reaction is preferably carried out at around room temperature for 10 to 24 hours.
C工程は、化合物(6)の水酸基のアシル保護基Aを除
去して化合物(7)を製造する工程である。Step C is a step for producing compound (7) by removing the acyl protecting group A of the hydroxyl group of compound (6).
本反応は、通常用いられる塩基性加水分解反応あるいは
加溶媒分解反応によって達成される。This reaction is achieved by a commonly used basic hydrolysis reaction or solvolysis reaction.
反応に使用される塩基としては、例えば水酸化ナトリウ
ム、水酸化カリウム、水酸化カルシウム、水酸化バリウ
ムのようなアルカリ金属若しくはアルカリ土類金属の水
酸化物があげられる。Examples of the base used in the reaction include alkali metal or alkaline earth metal hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide, and barium hydroxide.
使用される溶剤としては加水分解反応に用いられる溶剤
が特に限定なく用いられ、例えばメタノール、エタノー
ル、イソプロピルアルコールのようなアルコール類、エ
ーテル、テトラヒドロンラン、ジオキサン、ジメトキシ
エタンのようなエーテル類、ジメチルスルホキシドのよ
うなスルホキシド類、ジメチルホルムアミドのようなア
ミド類およびこれらの有機溶剤と水との混合溶剤をあげ
ることができる。反応温度は通常、室温付近乃至溶剤の
還流温度で行なわれる。The solvent used is not particularly limited to those used in hydrolysis reactions, such as alcohols such as methanol, ethanol, and isopropyl alcohol, ethers, ethers such as tetrahydrone, dioxane, and dimethoxyethane, and dimethyl sulfoxide. Examples include sulfoxides such as , amides such as dimethylformamide, and mixed solvents of these organic solvents and water. The reaction temperature is usually around room temperature to the reflux temperature of the solvent.
反応時間は反応温度などによって異なるが、通常は1乃
至24時間である。The reaction time varies depending on the reaction temperature, etc., but is usually 1 to 24 hours.
D工程は、化合物(7)のフェノール性水酸基をハライ
ド化合物(8)によってアルキル化して、化合物(2)
を製造する工程である。In step D, the phenolic hydroxyl group of compound (7) is alkylated with halide compound (8) to form compound (2).
This is the process of manufacturing.
本反応は、通常のアルキル化の方法に従って実施するこ
とができるが、?etrahedron 、 30巻、
1379頁(1,974年)に記載された相間移動触
媒を用いる方法で好適に行なわれる。使用される溶剤と
しては通常、過剰のハライド化合物(8)と水との混合
溶剤が好適であるが、例えばジクロロメタン、クロロホ
ルムのよ5なハロゲン化炭化水素類またはベンゼン、ト
ルエンのような芳香族炭化水素類などの有機溶剤と水と
の混合溶剤を使用することもできる。反応に使用される
塩基としては例えば水酸化ナトリウム、水酸化カリウム
、炭酸ナトリウム、炭酸カリウムのようなアルカリ金属
の水酸化物または炭酸塩があげられる。また、使用され
る相間移を触媒としては、硫酸水素テトラブチルアンモ
ニウムが好適である。反応温度は10乃至50℃が好適
であり、反応時間は反応温度などによって異なるが、1
0分間乃至10時間である。This reaction can be carried out according to the usual alkylation method, but? etrahedron, volume 30,
This is suitably carried out by the method using a phase transfer catalyst described on page 1379 (1,974). The solvent to be used is usually a mixed solvent of excess halide compound (8) and water, but for example, halogenated hydrocarbons such as dichloromethane and chloroform, or aromatic hydrocarbons such as benzene and toluene. A mixed solvent of an organic solvent such as hydrogen and water can also be used. Examples of the base used in the reaction include alkali metal hydroxides or carbonates such as sodium hydroxide, potassium hydroxide, sodium carbonate, and potassium carbonate. Further, as a phase transfer catalyst to be used, tetrabutylammonium hydrogen sulfate is suitable. The reaction temperature is preferably 10 to 50°C, and the reaction time varies depending on the reaction temperature, etc.
The duration ranges from 0 minutes to 10 hours.
発明の効果
前記一般式(1]で表わされる本発明の目的化合物は、
リノール酸、リノール酸エチルのような不飽和脂肪酸お
よびそのエステル類に対し、高い酸化防止作用を有する
ことから、生体内において不飽和脂肪酸の構成率の高い
リン脂質の酸化を防止し得ることが予想され# nto
chem。Effect of the invention The target compound of the present invention represented by the general formula (1) is:
Since it has a high antioxidant effect on unsaturated fatty acids and their esters such as linoleic acid and ethyl linoleate, it is expected that it will be able to prevent the oxidation of phospholipids, which have a high proportion of unsaturated fatty acids, in vivo. # nto
chem.
Biophya、Res 、Commun、 9 ’4
.734−737頁(1980年)に示されるラット肝
ミクロソーム脂質の過酸化抑制試験において、強力な過
酸化脂質低下作用を有するのみならず、アロ中サンで誘
発せしめた実験的高脂血症マウスの試験において、血中
過酸化脂質、トリグリセライドおよびコレステロールを
低下せしめるなどの優れた血中脂質代謝改善作用を示す
化合物である。Biophya, Res, Commun, 9'4
.. In the peroxidation inhibition test of rat liver microsomal lipids shown on pages 734-737 (1980), it not only had a strong lipid peroxide lowering effect, but also showed that In tests, this compound shows excellent effects on improving blood lipid metabolism, such as lowering blood peroxide lipids, triglycerides, and cholesterol.
以上の試験の結果から本発明のフェノキシアルカン酸誘
導体+11は、人の高脂血症の治療に有用であることが
期待される。From the results of the above tests, the phenoxyalkanoic acid derivative +11 of the present invention is expected to be useful for treating hyperlipidemia in humans.
投与方法は、たとえば錠剤、カプセル剤、散剤、顆粒剤
などとして経口的に用いられるほか注射剤(静脈内、皮
下、筋肉内)、坐剤などとして、非経口的に投与するこ
とができる。その投与量は症状、年令などによって異な
るが、例えば高脂血症の治療剤として用いる場合は成人
につき通常1日50ダ乃至5fを経口的または非経口的
に投与することができる。Administration methods include oral administration in the form of tablets, capsules, powders, granules, etc., as well as parenteral administration in the form of injections (intravenous, subcutaneous, intramuscular), suppositories, etc. The dosage varies depending on symptoms, age, etc., but when used as a therapeutic agent for hyperlipidemia, for example, 50 to 5 f per day can be administered orally or parenterally to an adult.
以下に実施例および参考例をあげて本発明をさらに具体
的に説明する。EXAMPLES The present invention will be explained in more detail with reference to Examples and Reference Examples below.
実施例1(a)
ジイソプロピルアミン149.5R9とテトラヒドロフ
ラン1.5 j!/の混合物に5S%油性水素化ナトリ
ウム91.5〜を加える。次いでイソ酪酸124、OI
Qのテトラヒドロフラン(1,5R1)溶液を滴下した
後、窒素気流中で10分間加熱還流する。反応混合物を
一5〜0℃に冷却し、15俤/7ブチルリチウムーヘキ
サン溶液をαTゴ滴下する。15分間同温度でかくはん
し、30−ルジメチルシリルオキシ−2,3,5−)リ
メチルフエノキシ)プロピル430〜のテトラヒドロフ
ラン(1プ)溶液を滴下する。その後20Cで30分間
、3G−35℃で30分間、さらに室温で一夜かくはん
する。テトラヒドロフランを減圧下留去し、残渣に水3
5ゴを加え、水層をエーテルで洗浄する。水層にヘキサ
ンと濃塩酸α511Llを加えて室温で1時間かくはん
する。有機層を水洗後無水硫酸す) IJウムで乾燥す
る。Example 1 (a) Diisopropylamine 149.5R9 and tetrahydrofuran 1.5 j! Add 91.5 ~ of 5S% oily sodium hydride to the mixture of /. Then isobutyric acid 124, OI
After adding a solution of Q in tetrahydrofuran (1,5R1) dropwise, the mixture was heated under reflux for 10 minutes in a nitrogen stream. The reaction mixture was cooled to -5 to 0°C, and a 15/7 butyllithium-hexane solution was added dropwise. The mixture was stirred at the same temperature for 15 minutes, and a solution of 30-dimethylsilyloxy-2,3,5-)limethylphenoxy)propyl 430~ in tetrahydrofuran (1p) was added dropwise. Thereafter, the mixture was stirred at 20C for 30 minutes, at 3G-35C for 30 minutes, and then at room temperature overnight. Tetrahydrofuran was distilled off under reduced pressure, and 3 parts of water was added to the residue.
5. Add water and wash the aqueous layer with ether. Hexane and 511 Ll of concentrated hydrochloric acid α are added to the aqueous layer, and the mixture is stirred at room temperature for 1 hour. The organic layer is washed with water and then dried with anhydrous sulfuric acid (IJum).
溶媒を留去して得られた残渣をシリカゲルカラムクロマ
トグラフィー(溶離液;ベンゼン:酢酸エチル−10:
1)に付し、目的化合物を得た。The residue obtained by distilling off the solvent was subjected to silica gel column chromatography (eluent; benzene:ethyl acetate-10:
1) to obtain the target compound.
融点: 103−140
実施例1(b)
5−(4−t−ブチルジメチルシリルオキシ−24λ5
−トリメチルフェノキシ)−2,2−ジメチルペンタン
酸1?61119、フッ化テトラブチルアンモニウム3
水和物364吋、テトラヒドロフラン1−および酢酸a
2fの混合物を室温で3時間かくはんする。反応終了後
、テトラヒドロフランを減圧下留去して、水とエーテル
を加える。有機層を分け、硫酸マグネシウムで乾燥する
。溶媒を留去して得られた粉末をベンゼンとヘキサンの
混合溶媒より再結晶して目的物を得た。Melting point: 103-140 Example 1(b) 5-(4-t-butyldimethylsilyloxy-24λ5
-trimethylphenoxy)-2,2-dimethylpentanoic acid 1?61119, tetrabutylammonium fluoride 3
hydrate 364 inches, tetrahydrofuran 1- and acetic acid a
Stir the 2f mixture at room temperature for 3 hours. After the reaction is complete, tetrahydrofuran is distilled off under reduced pressure, and water and ether are added. Separate the organic layer and dry with magnesium sulfate. The powder obtained by distilling off the solvent was recrystallized from a mixed solvent of benzene and hexane to obtain the desired product.
融点:8F−89℃
実施例2
5−(4−ヒドロ中シー2.3.5−)リメチルフエノ
中シ)−2,2−ジメチルペンタン酸α3tとテトラヒ
ドロフラン5−の混合物にリチウムアルミナムハイドラ
イド15α7すを加え、室温で2時間かくはんする。反
応液を氷水にあけ、希塩酸で酸性にしてベンゼンで抽出
する。無水硫酸ナトリウムで乾燥後、溶媒を留去して得
られた残渣をシリカゲルカラムクロマトグラフィー(溶
離液;ベンゼン:酢酸エチル−6:1)に付して、目的
化合物を得た。Melting point: 8F-89℃ Example 2 Lithium aluminum hydride 15α7 was added to a mixture of 5-(4-hydro-2.3.5-)-2,2-dimethylpentanoic acid α3t and tetrahydrofuran 5-. Add and stir at room temperature for 2 hours. Pour the reaction solution into ice water, acidify with dilute hydrochloric acid, and extract with benzene. After drying over anhydrous sodium sulfate, the solvent was distilled off, and the resulting residue was subjected to silica gel column chromatography (eluent: benzene:ethyl acetate-6:1) to obtain the target compound.
融点ニア8−79℃
実施例1および2と同様にして、以下に示す実施例3乃
至6の化合物を得た。Melting point near 8-79°C Compounds of Examples 3 to 6 shown below were obtained in the same manner as in Examples 1 and 2.
1:11
参考例1
フェノール
トリメチルヒドロキノン3.5?、ジクロロメタン25
ゴおよびピリジン6ゴの混合物に塩化ピバロイル2.8
1のジクロロメタン(2(111Ll)溶液を滴下し、
室温で一夜放置する。酢酸4,25−と水20mを加え
、有機層を分け、さらに水洗した後無水硫酸ナトリウム
で乾燥する。溶媒を留去して得られ九残渣をシリカゲル
カラムクロマトグラフィー(溶離液;ベンゼン:酢酸エ
チル−10:1)に付し、さらにヘキサンより再結晶し
て淡黄色プリズム状の目的化合物を得た。1:11 Reference Example 1 Phenoltrimethylhydroquinone 3.5? , dichloromethane 25
2.8 pivaloyl chloride in a mixture of 6 and pyridine
A dichloromethane (2 (111 Ll) solution of 1 was added dropwise,
Leave at room temperature overnight. 4,25-acetic acid and 20 mL of water are added, and the organic layer is separated, further washed with water, and then dried over anhydrous sodium sulfate. The residue obtained by distilling off the solvent was subjected to silica gel column chromatography (eluent: benzene:ethyl acetate - 10:1), and further recrystallized from hexane to obtain the target compound in the form of pale yellow prisms.
融点:120−121℃
参考例2
乙
2、λ6−ドリメチルー+4−ピバロイルオキシフェノ
ール2.7F、ジメチルホルムアミド10ゴおよびt−
ブチルジメチルクロロシラン1.92の混合物にイミダ
ゾール2.3fを徐々に加え、その後室温で一夜放置す
る。反応混合物を氷とアンモニア水の混合物中にあけ、
ヘキサンで抽出する。抽出液を水洗後、無水硫酸ナトリ
ウムで乾燥する。溶媒を留去して得られた残渣をシリカ
ゲルカラムクロマトグラフィー(溶離液;ベンゼン)に
付し、目的化合物を得た。Melting point: 120-121°C Reference example 2 Otsu 2, λ6-drimethyl-+4-pivaloyloxyphenol 2.7F, dimethylformamide 10g and t-
2.3 f of imidazole is gradually added to a mixture of 1.92 g of butyldimethylchlorosilane, and then left overnight at room temperature. Pour the reaction mixture into a mixture of ice and aqueous ammonia,
Extract with hexane. After washing the extract with water, it is dried over anhydrous sodium sulfate. The residue obtained by distilling off the solvent was subjected to silica gel column chromatography (eluent: benzene) to obtain the target compound.
融点:48−490
参考例3
4−t−ブチルジメチルシリルオキシ−24λ5−トリ
メチル−1−ピバロイルオキシベンゼン32.6tをジ
メチルホルムアミド60−に溶かし、ここに水酸化カリ
ウム219のメタノール(1oOd)溶液を窒素雰囲気
下、滴下する。室温で2日間放置後、製塩rR2at、
氷300fj?!び水11の混合物中にあけ、ヘキサン
で抽出する。有機層を水洗し、無水硫酸す) IJウム
で乾燥する。溶媒を留去して得られた残渣をシリカゲル
カラムクロマトグラフィー(溶離液;ベンゼン:酢酸エ
チル−20:1)に付し、淡褐色油状の目的化合物を得
た。Melting point: 48-490 Reference Example 3 32.6 t of 4-t-butyldimethylsilyloxy-24λ5-trimethyl-1-pivaloyloxybenzene was dissolved in 60-dimethylformamide, and 219 methanol (10Od) of potassium hydroxide was added thereto. The solution is added dropwise under nitrogen atmosphere. After being left at room temperature for 2 days, salt production rR2at,
Ice 300fj? ! Pour into a mixture of 11 parts of water and water and extract with hexane. The organic layer is washed with water and dried with anhydrous sulfuric acid and IJum. The residue obtained by evaporating the solvent was subjected to silica gel column chromatography (eluent: benzene:ethyl acetate-20:1) to obtain the target compound as a pale brown oil.
シリカゲル薄層クロマトグラフィーのRf値−145(
展開溶媒;ベンゼン:酢酸エチル−10:1)
参考例4
1二
炭酸ナトリウム6.5f、硫酸水素テトラブチルアンモ
ニウム8.5F、水酸化ナトリウム&8tおよび水10
0フからなる混合物に、窒素気流中激しくかくはんしな
がら、4−1−ブチルジメチルシリルオキシ−2,λ5
−トリメチルフェノール17fと1,3−ジブロモプロ
パン1309の混合物を滴下する。その後室温で2時間
かくはんを続ける。反応終了後有機層を分け、水理t−
サラに1,3−ジブロモプロパンで抽出し、無水硫酸ナ
トリウムで乾燥する。1.3−ジブロモプロパンを減圧
下留去して得られた残渣をシリカゲルカラムクロマトグ
ラフィー(溶離液;ヘキサンおよびヘキテン:ベンゼン
−10:1)に付し、目的化合物を得九〇
融点:45−46℃Rf value of silica gel thin layer chromatography -145 (
Developing solvent; benzene:ethyl acetate - 10:1) Reference example 4 1 Sodium dicarbonate 6.5f, tetrabutylammonium hydrogen sulfate 8.5F, sodium hydroxide &8t and water 10
While vigorously stirring in a nitrogen stream, 4-1-butyldimethylsilyloxy-2,λ5 was added to a mixture consisting of
- A mixture of trimethylphenol 17f and 1,3-dibromopropane 1309 is added dropwise. Then continue stirring at room temperature for 2 hours. After the reaction, the organic layer was separated and
The extract is extracted with 1,3-dibromopropane and dried over anhydrous sodium sulfate. The residue obtained by distilling off 1.3-dibromopropane under reduced pressure was subjected to silica gel column chromatography (eluent: hexane and hexene:benzene - 10:1) to obtain the target compound. 46℃
Claims (1)
アルキル基を示し、R^3は水素原子または低級アルキ
ル基を示し、R^4は水素原子または水酸基の保護基を
示し、R^5は水素原子、アルキル基または低級アルコ
キシ基を示し、R^6は水素原子、低級アルキル基また
は低級アルコキシ基を示し、Zは式−COOR^7基(
式中、R^7は水素原子または低級アルキル基を示す。 )または式−CH_2OR^8基(式中、R^8は水素
原子またはアシル基を示す。)を示し、nは1乃至10
の整数を示す。〕 を有するフェノキシアルカン酸誘導体およびその薬理上
許容される塩。[Claims] General formula▲ Numerical formula, chemical formula, table, etc.▼ [In the formula, R^1 and R^2 are the same or different and represent a lower alkyl group, and R^3 is a hydrogen atom or a lower alkyl group. , R^4 represents a hydrogen atom or a hydroxyl group protecting group, R^5 represents a hydrogen atom, an alkyl group or a lower alkoxy group, R^6 represents a hydrogen atom, a lower alkyl group or a lower alkoxy group, Z is the formula -COOR^7 group (
In the formula, R^7 represents a hydrogen atom or a lower alkyl group. ) or the formula -CH_2OR^8 group (in the formula, R^8 represents a hydrogen atom or an acyl group), and n is 1 to 10
indicates an integer. ] A phenoxyalkanoic acid derivative and a pharmacologically acceptable salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61050015A JPH0729967B2 (en) | 1986-03-07 | 1986-03-07 | Phenoxyalkanoic acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61050015A JPH0729967B2 (en) | 1986-03-07 | 1986-03-07 | Phenoxyalkanoic acid derivative |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6185690A Division JP2612421B2 (en) | 1994-08-08 | 1994-08-08 | Phenoxyalkanoic acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62207236A true JPS62207236A (en) | 1987-09-11 |
JPH0729967B2 JPH0729967B2 (en) | 1995-04-05 |
Family
ID=12847169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61050015A Expired - Lifetime JPH0729967B2 (en) | 1986-03-07 | 1986-03-07 | Phenoxyalkanoic acid derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0729967B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166398A (en) * | 1991-06-21 | 1992-11-24 | Warner-Lambert Co. | 4-oxy-substituted phenoxyalkyl carboxylic acid, ester, and alcohol derivatives as antihyper-cholesterolemic and antiatherosclerotic agents |
US5412112A (en) * | 1994-06-14 | 1995-05-02 | Industrial Technology Research Institute | Derivatives and preparation of 2,2-dimethyl-5-substituted phenoxy-pentanoic acids |
EP0763527A1 (en) * | 1995-09-14 | 1997-03-19 | Adir Et Compagnie | Substituted 2,2-dimethyl-omega-phenoxy alkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
WO1997015546A1 (en) * | 1995-10-26 | 1997-05-01 | Nippon Shinyaku Co., Ltd. | Carboxylic acid derivatives and pharmaceutical compositions |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6051036B2 (en) | 2012-12-25 | 2016-12-21 | 株式会社Kelk | Circulating cooling and heating device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4413011A (en) * | 1981-02-26 | 1983-11-01 | Warner-Lambert Company | Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method |
JPS606667A (en) * | 1983-06-24 | 1985-01-14 | Yamanouchi Pharmaceut Co Ltd | Imidazole derivative and its preparation |
JPS6013761A (en) * | 1983-07-05 | 1985-01-24 | Yamanouchi Pharmaceut Co Ltd | Novel pyridyl ether derivative |
-
1986
- 1986-03-07 JP JP61050015A patent/JPH0729967B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4413011A (en) * | 1981-02-26 | 1983-11-01 | Warner-Lambert Company | Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method |
JPS606667A (en) * | 1983-06-24 | 1985-01-14 | Yamanouchi Pharmaceut Co Ltd | Imidazole derivative and its preparation |
JPS6013761A (en) * | 1983-07-05 | 1985-01-24 | Yamanouchi Pharmaceut Co Ltd | Novel pyridyl ether derivative |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166398A (en) * | 1991-06-21 | 1992-11-24 | Warner-Lambert Co. | 4-oxy-substituted phenoxyalkyl carboxylic acid, ester, and alcohol derivatives as antihyper-cholesterolemic and antiatherosclerotic agents |
US5412112A (en) * | 1994-06-14 | 1995-05-02 | Industrial Technology Research Institute | Derivatives and preparation of 2,2-dimethyl-5-substituted phenoxy-pentanoic acids |
EP0763527A1 (en) * | 1995-09-14 | 1997-03-19 | Adir Et Compagnie | Substituted 2,2-dimethyl-omega-phenoxy alkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
FR2738817A1 (en) * | 1995-09-14 | 1997-03-21 | Adir | NOVEL SUBSTITUTED 2,2-DIMETHYL-OMEGA-PHENOXY ALKANOIC ACIDS AND ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
WO1997015546A1 (en) * | 1995-10-26 | 1997-05-01 | Nippon Shinyaku Co., Ltd. | Carboxylic acid derivatives and pharmaceutical compositions |
Also Published As
Publication number | Publication date |
---|---|
JPH0729967B2 (en) | 1995-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5294724A (en) | 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters and a process for their preparation | |
JPS6365657B2 (en) | ||
JP3233403B2 (en) | Optically active intermediate and method for producing the same | |
JPH04226939A (en) | Aromatic esters sensitive and insensitive to oxidant as inhibitor of homophilic mesospherical elastase | |
JPH0114215B2 (en) | ||
CA1324134C (en) | Process for preparing (rs)-2-(2,3-dihydro-5-hydroxy-4,6, 7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl) acetic acids and esters thereof, useful as mucoregulator and antihyschaemic drugs | |
CA2107150C (en) | Chromenic derivatives having a triene lateral chain, process for the preparation thereof and pharmaceutical compositions containing them | |
RU2054412C1 (en) | Quinone derivatives | |
JPS62207236A (en) | Phenoxyalkanoic acid derivative | |
JPH03215452A (en) | 2,4,6-substituted phenol derivative | |
AU642856B2 (en) | Naphthalene derivatives | |
JPH0414091B2 (en) | ||
CA1191153A (en) | Forms of diflunisal and related compounds | |
JP2846418B2 (en) | Naphthalene derivative | |
JP2612421B2 (en) | Phenoxyalkanoic acid derivatives | |
US4060691A (en) | 7-{3-Hydroxy-2-[4-hydroxy-4-(lower alkyl)-trans-1-octen-1-yl]-5-oxocyclopent-1-yl}heptanoic acids and esters | |
AU629594B2 (en) | Pyranylethyl-naphthalene derivatives | |
FR2468574A1 (en) | 4-CHLOROBIPHENYLALCOXYACETIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
JPH05221901A (en) | Secosterol derivative | |
JPH05221924A (en) | Secosterol compound | |
US4112114A (en) | Esters of 2-substituted-5-oxo-5H-dibenzo[a,d]cycloheptenes having pharmaceutical activity, and methods and compositions for the use thereof | |
JPS62149672A (en) | 4h-benzo(4, 5) cyclohepta (1, 2-b) thiophene derivative | |
JP2843081B2 (en) | Naphthalene derivative | |
JPH0139411B2 (en) | ||
WO1992008712A1 (en) | Flavane derivative or salt thereof and novel production process |